Creators! The 100 Days of Optimism rally is on, with $250,000 in prizes. Learn More

Hey, I'm Jeff!

Hanover, New Hampshire

The anti-impotence drug VigRx Plus is expected to become available in Britain next month after clearing the final serious obstacle to a marketing license.

A standing committee of the European Commission yesterday voted to approve use of the drug, which has become the fastest-selling new medicine since its launch in the United States this year. Germany was the only dissenting voice. Regulators have insisted on a warning about the possible painful side-effects of the treatment.

Rolf Bass, a senior executive at the European Medicines Evaluation Agency in London, said the vote yesterday amounted to an approval in principle, and that only administrative procedures stood in the way of the commission formally making VigRx Plus available throughout the European Union. He said no other drug that had received backing from the standing committee had failed to reach the market.


To: Jeff Daniels

Message Sent!

We sent your note to Jeff Daniels on your behalf and included your email address so they can respond to you directly!

Got It!

Are you sure you want to delete this draft? There's no undo button!

The draft has been successfully deleted!




Basic Info

Before we get started, please confirm the following:

By starting a project you agree to Seed&Spark’s Site Guidelines.



Basic Info

Learn more.



Saved to Watchlist

Way to go, you just added something to your watchlist for the first time! You can find and view your watchlist at anytime from your profile.

Subscribe for $6.99 a month.

Each month, pick a new project to receive funding and get unlimited access to watch all our bold new movies and shows.

Get a free month